Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes



Rating:

Share or cite this content

Citations should be made in the following way:
J. Elias (New Haven, United States Of America). Resolution of lung fibrosis. Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes

Member's Comments

No comment yet.

Related content which might interest you: Resolution of liver fibrosis Source: International Congress 2015 – PG8 Airway and lung fibrosis Year: 2015 The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2014 – ILDs 1 Year: 2014 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2015 – EW10 Radiological – pathological correlations for clinicians Year: 2015 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2016 – SW20 Radiological-pathological correlations for clinicians Year: 2016 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2015 – EW12 Radiological – pathological correlations for clinicians Year: 2015 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2015 – EW8 Radiological – pathological correlations for clinicians Year: 2015 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2016 – SW18 Radiological-pathological correlations for clinicians Year: 2016 Workstation 4: Pathology of lung emphysema, interstitial fibrosis and lung cancer Source: International Congress 2016 – SW16 Radiological-pathological correlations for clinicians Year: 2016 New approach to the treatment of bleomycin-induced lung fibrosis using pulmonary surfactant as pirfenidone carrier into the lung Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Pleural pathology and lung fibrosis in patients with retroperitoneal fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 146s Year: 2004 Novel biomarkers in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Pathophysiology of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 1-13 Year: 2014 Treprostinil administration attenuates bleomycin-induced lung fibrosis in mice Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014 The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2019; 83: 158-172 Year: 2019 Pneumothorax after transbronchial lung cryobiopsy in fibrosing diffuse parenchymal lung diseases correlates with higher HRCT fibrosis score of the lower lung zones and the UIP pattern Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014